← Animal Welfare Hub

🐕 Canine Cognitive Dysfunction — Welfare Guide

Companion AnimalsDog WelfareSenior DogsCognitive Health
Prevalence: Canine cognitive dysfunction syndrome (CCDS) affects an estimated 28% of dogs aged 11–12 years and 68% of dogs aged 15–16 years. It is significantly underdiagnosed and undertreated, causing unnecessary suffering in elderly dogs.

What is Canine Cognitive Dysfunction?

Canine cognitive dysfunction syndrome (CCDS) — sometimes called "doggy dementia" — is a neurodegenerative condition associated with beta-amyloid plaque deposition in the brain, similar to Alzheimer's disease in humans. It is a progressive, age-related condition causing deterioration of cognitive function, memory, learning, and awareness.

CCDS is distinct from normal aging. While all dogs experience some cognitive slowing with age, CCDS represents pathological deterioration that significantly impairs quality of life and causes distress.

Recognising CCDS — The DISHA Framework

Veterinary practitioners use the DISHA framework to assess cognitive dysfunction signs:

Any 2+ DISHA signs in a dog over 7 years warrants veterinary assessment for CCDS.

Welfare Implications

Suffering in CCDS

CCDS causes significant suffering through:

Carer Burden

CCDS also significantly affects dog owners. Nighttime disturbance, house soiling, and distressing behavioural changes cause substantial owner stress and are major factors in decisions about euthanasia. Supporting owners in CCDS management is an important welfare intervention.

Diagnosis

CCDS is a diagnosis of exclusion — other causes of behavioural change must be ruled out first:

The validated Canine Cognitive Dysfunction Rating Scale (CCDR) questionnaire is a useful screening tool. Neuroimaging (MRI) can support diagnosis but is not routinely available.

Management — Improving Quality of Life

Environmental Modifications

Cognitive Stimulation

Gentle mental engagement can slow cognitive decline:

Pharmaceutical Support

Nutritional Support

Diets supplemented with antioxidants, omega-3 fatty acids, and medium-chain triglycerides (MCT) have some evidence of benefit in CCDS. Commercial veterinary diets formulated for cognitive support are available.

Quality of Life Assessment and End-of-Life

As CCDS progresses, regular quality of life assessment is essential. Validated tools (HHHHHMM scale, VetMETICA) help owners and vets assess when quality of life has declined to a point where euthanasia may be the kindest option. Signs indicating poor quality of life include: continuous distress or confusion, failure to recognise owners, inability to rest or sleep, complete loss of toileting control with associated anxiety.